News Briefs

HM Capital Partners has selected JPMorgan to provide fund administration services. As part of the deal HM Capital's existing fund administration team will become part of JPMorgan Private Equity Fund Services, and will continue to support HM Capital as a third party administrator. http://www.hmcapital.com/ http://www.jpmorgan.com/

Callan Associates has promoted Greg Allen to president, with former president Ronald Peyton to remain as CEO and COO. Peyton also has been named firm chairman, with founder Edwin Callan becoming chairman emeritus. http://www.callan.com/  

Quadrangle Group has made the following promotions: Jeffrey Nordhaud to managing principal; David Crosby, Andrew Frey and Henry Ormond to principal; Stacey Harris, Amanda Siegel and Chun Won Yi to vice president; and Mike Gillin to vice president of fund operations. http://www.quadranglegroup.com/

Tim Whitmire has joined Edgeview Partners as vice president of marketing and communications. He previously headed The Associated Press' Charlotte, N.C. bureau. http://www.edgeviewpartners.com/

BioPassword Inc., a Issaquah, Wash.

Automated Trading Desk, a Mt. Pleasant, S.C.-based provider of electronic trade-execution services, has raised $60 million from Technology Crossover Ventures, in exchange for a minority ownership position. www.atdesk.com

Proprius Pharmaceuticals Inc., a San Diego-based drug developer focused on rheumatology and autoimmune diseases, has raised $11 million in Series A funding (with an option to expand up to $17 million). Atlas Venture led the deal, and was joined by Forward Ventures, CDIB BioScience Venture Management and returns backers Fog City Fund and Windamere Venture […]

Vincent Ng has joined Atlantic-Pacific Capital as a Hong Kong-based director. He previously was a manager with the fund placement advisory group of Deloitte & Touche Corporate Finance in Hong Kong. www.apcap.com

Split Rock Partners of Minneapolis has promoted Josh Baltzell to director, and also said that he will relocate to the firm's office in Menlo Park, California. Baltzall focused on medical device opportunities, and sits on the boards of Split Rock portfolio companies Emphasys Medical and Entellus. www.splitrock.com

F-star, a Vienna, Austria-based developer of antibodies, has raised Euro1.5 million in first-round funding from Atlas Venture. www.f-star.com